SH 04 - Gastrointestinal Cancer- Science Highlights

Presentations

• 08:00am - 08:05am ET

  Short-Course Radiotherapy-Based Total Neoadjuvant Therapy with or without a PD-1 Inhibitor in pMMR Locally Advanced Rectal Cancer: Short-Term Results from a Randomized Phase 3 Trial (STELLAR II)

  Speaker: Yuan Tang, MD - Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing
• 08:05am - 08:10am ET

  REDEL Trial: Phase II Trial of Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation

  Speaker: Jordan Kharofa, MD - University of Cincinnati, Cincinnati
• 08:10am - 08:15am ET

  Sexual Health and Post-Treatment Symptoms among Female Survivors of Anal Cancer

  Speaker: Ann Raldow, MD, MPH - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles
• 08:15am - 08:20am ET

  A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy Or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Pancreatic Adenocarcinoma, the SOFT Preop Study

  Speaker: William Hall, MD - Medical College of Wisconsin, Milwaukee
• 08:20am - 08:25am ET

  Initial Results of NRG Oncology NRG-GI003: A Phase III Randomized Trial of Protons vs. Photons for Hepatocellular Carcinoma (HCC)

  Speaker: Theodore Hong, MD - Dana-Farber Cancer Institute, Boston
• 08:25am - 08:30am ET

  Discussant

  Speaker: Jennifer Wo, MD, FASTRO - Massachusetts General Hospital/ Harvard Medical School, Boston